explore -WSS

explore

author：entertainment 2025-08-12 11:30:02 - browse：75

A new asthma treatment that could be administered just once every six months has succeeded in two Phase 3 trials, developer GlaxoSmithKline announced Tuesday.

The drug, depemokimab, is designed to treat asthma by targeting a protein called interleukin-5, or IL-5. The protein is linked to the type of inflammation found in most severe asthma cases, according to the pharma company.

Depemokimab hit its primary endpoints in the trials, reducing asthma attacks over a year’s time frame. The company didn’t disclose exact details from the SWIFT-1 and SWIFT-2 trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Study links childhood stress with decline in older age

focus

WSS

STAT's 2023 biotech VC rankings: ARCH Venture Partners tops list

States increasingly look to regulate hospital facility fees

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

FDA approves Sage Therapeutics’ rapid

Study links childhood stress with decline in older age

Actors' union, Hollywood studios squabble over which side to blame as strike enters 5th day

focus

explore

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

explore

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

Malaria cases in Florida and Texas: Here’s what you need to know

Plane’s emergency slide plummets from sky, hits Chicago home

Tori Bowie and the unacceptable rates of Black maternal death

How dance can help health care workers heal from trauma

Anesthesiologist group: stop taking Ozempic before surgery

Alnylam reports growth in sales of rare disease treatments

Hepatitis C has a cure — but many Americans still lack access to it

Lindsay Lohan welcomes 1st child with husband Bader Shammas

leisure time

FAA sets up new process for Hawaii air tour operators to fly at lower altitudes after fatal crashes

How to ethically and practically extend health care to all

Ebola public health emergency is over, WHO declares

Personalized medicine goes far beyond genetics

When waiting feels immoral: Empathy in the emergency department

'Reaching a detente': STAT's Helen Branswell on covering Covid

focus

entertainment

leisure time

explore